$6.19 Million is the total value of Copernicus Capital Management, LLC's 14 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 72.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $755,000 | -19.7% | 10,000 | -6.7% | 12.20% | -16.7% |
VRTX | Sell | VERTEX PHARMACEUTICALS INC | $645,000 | -11.5% | 3,000 | -2.8% | 10.42% | -8.3% |
TDOC | Sell | TELADOC HEALTH INC | $273,000 | -29.8% | 1,500 | -22.8% | 4.41% | -27.2% |
TBIO | Exit | TRANSLATE BIO INC | $0 | – | -12,091 | -100.0% | -3.48% | – |
ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -2,000 | -100.0% | -4.05% | – |
ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -3,740 | -100.0% | -4.47% | – |
NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -3,089 | -100.0% | -4.61% | – |
GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -2,788 | -100.0% | -5.02% | – |
IGMS | Exit | IGM BIOSCIENCES INC | $0 | – | -4,000 | -100.0% | -5.50% | – |
IQV | Exit | IQVIA HLDGS INC | $0 | – | -2,094 | -100.0% | -5.84% | – |
BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -11,327 | -100.0% | -10.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERTEX PHARMACEUTICALS INC | 15 | Q2 2021 | 28.6% |
THERMO FISHER SCIENTIFIC INC | 10 | Q3 2021 | 13.8% |
ZOETIS INC | 10 | Q1 2020 | 13.0% |
FATE THERAPEUTICS INC | 9 | Q3 2021 | 13.7% |
ILLUMINA INC | 9 | Q4 2019 | 11.8% |
BIOMARIN PHARMACEUTICAL INC | 8 | Q3 2021 | 14.7% |
BRISTOL-MYERS SQUIBB CO | 8 | Q4 2020 | 12.2% |
INTUITIVE SURGICAL INC | 7 | Q2 2019 | 11.8% |
STRYKER CORP | 7 | Q2 2019 | 11.6% |
IQVIA HLDGS INC | 7 | Q4 2020 | 8.2% |
View Copernicus Capital Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2021-11-15 |
13F-HR | 2021-08-16 |
13F-HR | 2021-05-17 |
13F-HR | 2021-02-16 |
13F-HR | 2020-11-16 |
13F-HR | 2020-08-14 |
13F-HR | 2020-05-14 |
13F-HR | 2020-02-14 |
13F-HR | 2019-11-14 |
13F-HR | 2019-08-14 |
View Copernicus Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.